The identification of familial, AD-linked mutations in the genes for amyloid-β precursor protein (APP) and presenilin (PS1 and PS2) associated with deregulation of Aβ peptide production suggests that APP metabolism is at the heart of the disease process. Here, APP is linked to Alzheimer disease.